StonvexLoading…
StonvexStonvexStonvexCore line items from AEYE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $10.55M | $40.31M | $29.82M | $19.59M |
Operating Income | $-1.88M | $-1.83M | $-1.02M | $-698.00K |
Net Income | $-2.11M | $-3.08M | $-2.02M | $-2.00K |
EPS (Diluted) | $-0.17 | $-0.25 | $-0.16 | $-0.12 |
Total Assets | $35.10M | $32.23M | $30.48M | $33.90M |
Total Liabilities | $31.92M | $27.43M | $24.83M | $26.55M |
Cash & Equivalents | $8.56M | $5.29M | $4.55M | $6.87M |
Free Cash Flow OCF − CapEx | $1.24M | $4.70M | $2.19M | $1.15M |
Shares Outstanding | 12.41M | 12.29M | 12.41M | 12.44M |